作者: Stanisław Szala , Magdalena Jarosz-Biej , Tomasz Cichoń , Ryszard Smolarczyk , Aleksander Sochanik
DOI: 10.1007/978-3-662-44946-2_22
关键词: Extracellular matrix 、 Medicine 、 Tumor microenvironment 、 CpG site 、 Antigen 、 Angiogenesis 、 Transforming growth factor 、 Cancer cell 、 Endoglin 、 Cancer research
摘要: During neoplastic progression, cancer cells recruit inflammatory (monocytes, neutrophils, mast, and dendritic cells, etc.), which become “educated” under the influence of factors released by (mainly cytokines). As a consequence, former lose their ability to present antigens. Instead, they involved in remodeling extracellular matrix stimulate formation blood vessels (angiogenesis). Proangiogenic act as immunosuppressants tumor milieu becomes proangiogenic immunosuppressive. Latest studies have demonstrated possibility reverting such proangiogenic/immunosuppressive microenvironment inhibits growth. Reverted anti-angiogenic immunostimulatory. Reversal is especially feasible with combinations immunomodulatory factors. For instance, VEGF, VEGFR2, or TGF-β activity inhibitors immunostimulants anticancer vaccines, CpG sequences, IL-12 were effective inhibiting growth experimental tumors. In our hands, DNA vaccine directed against endoglin (CD105), vascular endothelial cell-surface protein, when combined IL-12, led ca. 30 % cure rate mice bearing melanoma It appears that attempts therapeutically revert might merit further consideration.